The phenotypes of γδ T cells infiltrating human tumors and their role in anti-tumor immunity remain poorly understood. A new study demonstrates that Vδ1 lymphocytes with cytolytic potential and features of tissue-resident-memory differentiation are predictive of survival in patients with non–small-cell lung cancer.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Molecular Cancer Open Access 15 February 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fleming, C., Morrissey, S., Cai, Y. & Yan, J. Trends Cancer 3, 561–570 (2017).
Di Marco Barros, R. et al. Cell 167, 203–218.e17 (2016).
Suzuki, T., Hayman, L., Kilbey, A., Edwards, J. & Coffelt, S. B. Immunol. Rev. 298, 198–217 (2020).
Wu, Y. et al. Nat. Cancer https://doi.org/10.1038/s43018-022-00376-z (2022).
Payne, K. K. et al. Science 369, 942–949 (2020).
Zakeri, N. et al. Nat. Commun. 13, 1372 (2022).
Anadon, C. M. et al. Cancer Cell 40, 545–557.e13 (2022).
Rutkowski, M. R. et al. Cancer Cell 27, 27–40 (2015).
Savas, P. et al. Nat. Med. 24, 986–993 (2018).
Pan, Y. et al. Nature 543, 252–256 (2017).
Luoma, A. M., Castro, C. D. & Adams, E. J. Trends Immunol. 35, 613–621 (2014).
Deseke, M. & Prinz, I. Cell Mol. Immunol. 17, 914–924 (2020).
Willcox, C. R. et al. Immunity 51, 813–825.e14 (2019).
Rigau, M. et al. Science 367, eaay5516 (2020).
Brandes, M. et al. Proc. Natl Acad. Sci. USA 106, 2307–2312 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.R.C.-G. has stock options in Compass Therapeutics, Anixa Biosciences and Alloy Therapeutics; conducts sponsored research for Anixa Biosciences; receives honoraria from Alloy Therapeutics and Leidos; and has intellectual property with Compass Therapeutics and Anixa Biosciences.
Rights and permissions
About this article
Cite this article
Conejo-Garcia, J.R., Innamarato, P. γδ T cells share the spotlight in cancer. Nat Cancer 3, 657–658 (2022). https://doi.org/10.1038/s43018-022-00396-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-022-00396-9
This article is cited by
-
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Molecular Cancer (2023)